Landmark Analysis Supports New Endpoints for Kidney Disease Trials
August 28, 2019
August 28, 2019
NEW YORK, Aug. 28 -- The National Kidney Foundation issued the following news release:
The American Journal of Kidney Diseases (AJKD) will publish today an article summarizing the deliberations and recommendations from a Scientific Workshop that was a joint effort of the National Kidney Foundation (NKF), the Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
The report, titled "Change in Albuminuria and GFR as End Points for Clinical Trials . . .
The American Journal of Kidney Diseases (AJKD) will publish today an article summarizing the deliberations and recommendations from a Scientific Workshop that was a joint effort of the National Kidney Foundation (NKF), the Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
The report, titled "Change in Albuminuria and GFR as End Points for Clinical Trials . . .